Vir Biotechnology, Inc.VIRNASDAQ

Revenue (LTM)

$69M

-7.6% YoY

Net Income (LTM)

$-438M

+16.1% YoY

Free Cash Flow

$-397M

Revenue CAGR (5Y)

+0.4%

Marginsdeclining

FCF($0.4B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	1,095	1,616↑47.5%	86↓94.7%	74↓13.9%	69↓7.6%
Gross Profit	582	995↑71.1%	-487↓148.9%	-404↑16.9%	57↑114.1%
Operating Income	421	833↑98.0%	-684↓182.1%	-587↑14.2%	-468↑20.3%
Net Income	529	516↓2.4%	-615↓219.2%	-522↑15.1%	-438↑16.1%
EBITDA	427	840↑96.9%	-642↓176.4%	-509↑20.7%	-426↑16.3%
EPS Diluted	3.96	3.83↓3.3%	-4.59↓219.8%	-3.83↑16.6%	-3.16↑17.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	348	849↑144.0%	242↓71.5%	223↓7.7%	234↑5.0%
Total Current Assets	1,563	2,519↑61.2%	1,588↓37.0%	1,042↓34.4%	514↓50.7%
Total Assets	1,954	2,802↑43.4%	1,919↓31.5%	1,399↓27.1%	1,003↓28.3%
Total Current Liabilities	341	511↑49.8%	175↓65.7%	120↓31.8%	93↓22.4%
Total Liabilities	522	724↑38.6%	329↓54.6%	248↓24.4%	238↓4.4%
Total Equity	1,432	2,078↑45.1%	1,590↓23.5%	1,150↓27.7%	765↓33.5%
Total Debt	137	128↓6.9%	125↓2.7%	98↓21.4%	187↑90.9%
Net Debt	-210	-721↓242.6%	-117↑83.8%	-125↓6.9%	-47↑62.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-48	1,663↑3595.0%	-779↓146.8%	-446↑42.7%	-392↑12.2%
Capital Expenditure	-22	-68↓211.7%	-22↑68.3%	-7↑66.2%	-5↑33.8%
Free Cash Flow	-69	1,595↑2398.4%	-800↓150.2%	-454↑43.3%	-397↑12.6%
Stock-Based Comp	84	102↑21.8%	0	78	49↓37.5%
Net Change in Cash	-88	505↑672.9%	-606↓220.2%	57↑109.5%	-78↓235.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance